Albert Labs International (FRA:VB50) Revenue : € Mil (TTM As of Mar. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Revenue?

Albert Labs International's revenue for the six months ended in Mar. 2023 was €0.00 Mil. Albert Labs International does not have enough years/quarters to calculate its revenue for the trailing twelve months (TTM) ended in Mar. 2023. Albert Labs International's Revenue per Share for the six months ended in Mar. 2023 was €0.00. Albert Labs International does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

Albert Labs International Revenue Historical Data

The historical data trend for Albert Labs International's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Revenue Chart

Albert Labs International Annual Data

Trend

Dec21

Dec22

Revenue

Albert Labs International Semi-Annual Data
	Mar21	Mar22	Mar23
Revenue	-	-	-

Competitive Comparison of Albert Labs International's Revenue

For the Biotechnology subindustry, Albert Labs International's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Albert Labs International's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Albert Labs International's Revenue distribution charts can be found below:

* The bar in red indicates where Albert Labs International's Revenue falls into.

Albert Labs International Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Albert Labs International (FRA:VB50) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Albert Labs International Revenue Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert Labs International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (FRA:VB50) » Definitions » Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6

Website

https://www.albertlabs.com

Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International Headlines

No Headlines